Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 Mar;43(3):485–495. doi: 10.1172/JCI104934

Carbohydrate Metabolism in Two Forms of Hyperglyceridemia *

Jerome L Knittle 1, E H Ahrens Jr 1
PMCID: PMC441942  PMID: 14135500

Full text

PDF
485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADLERSBERG D., WANG C. I. Syndrome of idiopathic hyperlipemia, mild diabetes mellitus, and severe vascular damage. Diabetes. 1955 May-Jun;4(3):210–218. doi: 10.2337/diab.4.3.210. [DOI] [PubMed] [Google Scholar]
  2. AHRENS E. H., Jr, HIRSCH J., OETTE K., FARQUHAR J. W., STEIN Y. Carbohydrate-induced and fat-induced lipemia. Trans Assoc Am Physicians. 1961;74:134–146. [PubMed] [Google Scholar]
  3. AHRENS E. H., Jr, INSULL W., Jr, BLOMSTRAND R., HIRSCH J., TSALTAS T. T., PETERSON M. L. The influence of dietary fats on serum-lipid levels in man. Lancet. 1957 May 11;272(6976):943–953. doi: 10.1016/s0140-6736(57)91280-1. [DOI] [PubMed] [Google Scholar]
  4. ANTONIADES H. N., PYLE H. M., BOUGAS J. A. Tolbutamide and regulation of endogenous insulin. Diabetes. 1962;11(Suppl):34–35. [PubMed] [Google Scholar]
  5. ANTONIS A., BERSOHN I. Serum-triglyceride levels in South African Europeans and Bantu and in ischaemic heart-disease. Lancet. 1960 May 7;1(7132):998–1002. doi: 10.1016/s0140-6736(60)90886-2. [DOI] [PubMed] [Google Scholar]
  6. BALLY P. R., CAHILL G. F., Jr, LEBOEUF B., RENOLD A. E. Studies on rat adipose tissue in vitro. V. Effects of glucose and insulin on the metabolism of palmitate-1-C14. J Biol Chem. 1960 Feb;235:333–336. [PubMed] [Google Scholar]
  7. BEIGELMAN P. M., TRANQUADA R. E. Serum insulin-like activity in untreated diabetics. Diabetes. 1962 May-Jun;11:179–182. [PubMed] [Google Scholar]
  8. BIERMAN E. L., HAMLIN J. T., 3rd The effect of insulin and glucagon on the removal of C-14-labeled particulate triglyceride from plasma in man. Metabolism. 1963 Jul;12:666–672. [PubMed] [Google Scholar]
  9. BIERMAN E. L., HAMLIN J. T., 3rd The hyperlipemic effect of a low-fat, high-carbohydrate diet in diabetic subjects. Diabetes. 1961 Nov-Dec;10:432–437. doi: 10.2337/diab.10.6.432. [DOI] [PubMed] [Google Scholar]
  10. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. FREDRICKSON D. S., ONO K., DAVIS L. L. LIPOLYTIC ACTIVITY OF POST-HEPARIN PLASMA IN HYPERGLYCERIDEMIA. J Lipid Res. 1963 Jan;4:24–33. [PubMed] [Google Scholar]
  12. HAVEL R. J., GORDON R. S., Jr Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest. 1960 Dec;39:1777–1790. doi: 10.1172/JCI104202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. HIRSCH E. F., PHIBBS B. P., CARBONARO L. Parallel relation of hyperglycemia and hyperlipemia (esterified fatty acids) in diabetes. AMA Arch Intern Med. 1953 Jan;91(1):106–117. doi: 10.1001/archinte.1953.00240130114011. [DOI] [PubMed] [Google Scholar]
  14. KIRTLEY W. R., WAIFE S. O., HELMER O. M., PECK F. B. Effect of purified glucagon (hyperglycemic-glycogenolytic factor, HGF) on carbohydrate and corticoid metabolism in normal and diabetic subjects. Diabetes. 1953 Sep-Oct;2(5):345–349. doi: 10.2337/diab.2.5.345. [DOI] [PubMed] [Google Scholar]
  15. RENOLD A. E., MARTIN D. B., DAGENAIS Y. M., STEINKE J., NICKERSON R. J., SHEPS M. C. Measurement of small quantities of insulin-like activity using rat adipose tissue. I. A proposed procedure. J Clin Invest. 1960 Sep;39:1487–1498. doi: 10.1172/JCI104168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. SALT H. B., WOLFF O. H., NESTADT A., LLOYD J. K. Control of lipaemia in children with diabetes mellitus; the role of insulin and the effects of a diet rich in unsaturated fatty acids. Lancet. 1960 Jan 9;1(7115):71–75. doi: 10.1016/s0140-6736(60)92897-x. [DOI] [PubMed] [Google Scholar]
  17. SELTZER H. S. Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood. J Clin Invest. 1962 Feb;41:289–300. doi: 10.1172/JCI104482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. SHIPP J. C., MUNROE J. F. Effects of sulfonylurea compounds on hyperlipemia and hypercholesteremia in patients with minimal impairment of glucose tolerance. Diabetes. 1962;11(Suppl):69–73. [PubMed] [Google Scholar]
  19. UNGER R. H., MADISON L. L. A new diagnostic procedure for mild diabetes mellitus; evaluation of an intravenous tolbutamide response test. Diabetes. 1958 Nov-Dec;7(6):455–461. doi: 10.2337/diab.7.6.455. [DOI] [PubMed] [Google Scholar]
  20. WADDELL W. R., GEYER R. P., HURLEY N., STARE F. J. Abnormal carbohydrate metabolism in patients with hypercholesterolemia and hyperlipemia. Metabolism. 1958 Nov;7(6):707–716. [PubMed] [Google Scholar]
  21. YALOW R. S., BLACK H., VILLAZON M., BERSON S. A. Comparison of plasma insulin levels following administration of tolbutamide and glucose. Diabetes. 1960 Sep-Oct;9:356–362. doi: 10.2337/diab.9.5.356. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES